ArticleThe Journal of clinical investigation2024

FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression.

Atsushi Okato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.